SCROLL

Down Arrow

Say HELLO

to the first FBS

created for biotherapy

Seraworx created TheraMAX FBS to make it easier to control variation and eliminate risk in cell, gene, and immunotherapy.

Wave GOODBYE

to variation and risk

Seraworxbottle.png

PERFORMANCE TESTED

Each lot of TheraMAX FBS

is prequalified for performance

CONTROL 

VARIATION

Pretesting confirms control of serum-derived variation

ELIMINATE

RISK

De-risk your process and product with a more controlled,

characterized FBS

mark1.png

All SIGNAL

no noise

TheraMAX FBS is a highly characterized, prequalified FBS that allows detection of maximum cellular response without introducing background and variation to assay conditions—making it easier to develop more controlled, robust, and reproducible outcomes.

1

QUALITY BY DESIGN

Smart process design directs each step in the supply chain to control variation and maximize potency, purity, and safety.

2

ZERO TO ULTRA-LOW BACKGROUND

Pretesting confirms zero to ultra-low levels of background in each lot, eliminating serum-derived variation from assay conditions.

3

MAXIMUM SIGNAL-TO-NOISE RATIO

On-target cell signaling is more easily detected when noise is controlled.

4

IMPROVED DATA QUALITY

Broader, more dynamic range of data is enabled that improves response detection and measurement, including identification of low responders.

5

DE-RISK PROCESS AND PRODUCT

Controlling serum-derived variation allows other variables to be identified and controlled for optimal therapeutic effect and minimal toxicity.

6

ACCELERATE DEVELOPMENT

TheraMAX FBS makes it easier to accelerate development and deliver more controlled, robust, and reproducible outcomes.

Stop troubleshooting the variation in your data and shift your focus to the goal-driven activities of product characterization and the standardization of manufacturing.

Shift your FOCUS

READY TO GET STARTED? 

Submit the form, and we will help you get started.

mark1.png